Deadline deadline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deadline.com Daily Mail and Mail on Sunday newspapers.
by Tyler Durden
Wednesday, Apr 21, 2021 - 02:45 AM
While American lawmakers have taken steps to shield US pharma companies from any legal blowback caused by COVID vaccines, drugmakers in Europe haven t been so lucky. And after widespread skepticism of the AstraZeneca-Oxford vaccine, what was supposed to be the workhorse of the global immunization rollout before reports of rare and deadly blood clots inspired regulators around the comment to either halt the jab, or impose limits on its use.
And now, all these issues will be dredged up again as AstraZeneca is hit by lawsuits filed by the families of those who died from rare blood clots potentially linkted to the vaccine. In what appears to be a first, Sky News reported Monday that the family of an Italian woman who died from a case of vaccine-linked clots are suing to officially establish whether the jab was at fault in her death.
Live and Local Podcast - Supporting Live Local Music On The Isle Of Wight
COVID-19: Family of Italian woman who died after Oxford-AstraZeneca vaccine launch legal action
The case comes after 55-year-old Augusta Turiaco, from Messina, Sicily, received her
COVID jab on 11 March before her condition worsened in the days following her vaccination.
The music teacher was keen to receive a jab as she worked with young people and even expressed her joy at getting the dose in a Facebook post, writing fatto - the Italian word for done .
Despite feeling unwell afterwards, she returned to work, posting two days later to reassure worried friends saying: Andra tutto bene - everything will be alright .
COVID-19: Family of Italian woman who died after Oxford-AstraZeneca vaccine launches legal action yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.